INmune Bio, Inc. (INMB)
NASDAQ: INMB · Real-Time Price · USD
4.400
-0.020 (-0.45%)
Dec 20, 2024, 4:00 PM EST - Market closed
INmune Bio Employees
As of December 31, 2023, INmune Bio had 17 total employees, including 11 full-time and 6 part-time employees. The number of employees increased by 7 or 70.00% compared to the previous year.
Employees
17
Change (1Y)
7
Growth (1Y)
70.00%
Revenue / Employee
$2,471
Profits / Employee
-$2,427,765
Market Cap
97.56M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| MultiPlan | 2,800 |
| FONAR | 561 |
| Veru Inc. | 189 |
| Adverum Biotechnologies | 121 |
| electroCore | 68 |
| Assembly Biosciences | 65 |
| Journey Medical | 41 |
INMB News
- 17 days ago - OmniScience Inc. and INmune Bio Inc. Partner to Accelerate a Phase 2 Alzheimer's Trial with Vivo, a Novel genAI Clinical Trial Control Tower - Business Wire
- 7 weeks ago - INmune Bio, Inc. (INMB) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - INmune Bio Inc. Announces Third Quarter 2024 Results and Provides Business Update - GlobeNewsWire
- 7 weeks ago - INmune Bio Inc. to Host Webinar on Cognitive Testing Using EMACC and CDR-SB - GlobeNewsWire
- 2 months ago - INmune Bio Inc. Announces Publication in Cell Reports Demonstrating XPro™ Promotes Remyelination - GlobeNewsWire
- 2 months ago - INmune Bio Inc. to Report Third Quarter 2024 Financial Results and Provide Corporate Update on October 31, 2024 - GlobeNewsWire
- 2 months ago - INmune Bio Inc. to Participate in the Maxim Healthcare Virtual Summit - GlobeNewsWire
- 2 months ago - INmune Bio: NK Cell Therapy INKmune For mCRPC Is Another Shot On Goal - Seeking Alpha